The monoclonal antibody Alz-50, used to reveal cytoskeletal changes in Alzheimer’s disease, also reacts with somatostatinergic neurons in the normal human hypothalamus and adjoining areas

Research group Swaab

Publication year 1994

Published in Brain Research

Authors J.A.P. van de Nes, A.A. Sluiter, C.W. Pool, W. Kamphorst, R. Ravid, D.F. Swaab

Support our work!

The Friends Foundation facilitates groundbreaking brain research. You can help us with that.